Latest California Healthline Stories
Must-Reads Of The Week From Brianna Labuskes
Newsletter editor Brianna Labuskes wades through hundreds of health care policy stories each week, so you don’t have to.
Flavor Bans Multiply, But Menthol Continues to Divide
As states and communities ban the sale of flavored tobacco products linked to vaping, anti-smoking activists are piggybacking on the momentum to target menthol cigarettes. But some African Americans say menthol cigarette bans will lead to discrimination.
FDA Keeps Brand-Name Drugs On A Fast Path To Market ― Despite Manufacturing Concerns
The agency approved Gilead’s “game changer” hepatitis C cure, bypassing concerns raised by its own federal inspectors. The problems they found at the company’s main U.S. drug-testing laboratory in Foster City, Calif., were so bad, they recommended withholding approval.
Monstruoso marketing de millones de dólares impulsa el uso de mamografías 3D
La investigación de KHN muestra que el dinero de la industria ha delineado políticas, a la opinión pública y a la atención al paciente en torno a las pruebas 3D.
A Million-Dollar Marketing Juggernaut Pushes 3D Mammograms
Companies are aggressively touting 3D mammograms, although there’s no evidence they save lives.
Vapers Accuse Officials Of Overreach As Investigation Into Deadly Lung Illness Lags
With federal authorities offering few details about what is causing the deadly outbreak of vaping-related lung illnesses, vaping advocates are crafting an alternative narrative reverberating through online communities.
Una crema para aclarar la piel deja a una mujer en coma. Podría suceder de nuevo
La crema facial que enfermó a la mujer de Sacramento fue manipulada después de su fabricación, en México. Estas cremas suelen atraer al consumidor latino.
Skin-Lightening Cream Put A Woman Into A Coma. It Could Happen Again.
A Sacramento woman is in a coma after using a face cream from Mexico. It is the nation’s first case of methylmercury poisoning from a cosmetic, and public health officials can do almost nothing to prevent other contaminated cosmetics from hitting the shelves.
At Raucous Hearing, No Unity On Vaping Issues
A hearing before a House Oversight and Reform Committee panel on how to address the crisis of respiratory injuries related to vaping turned surprisingly partisan.
As Off-Label Use Spreads, Supplies Of Niche Drugs And Patients’ Patience Grow Short
The reasons behind one particular shortage of a therapy known as IVIG are complicated, stemming from increased demand and the medication’s long production window.